- PRICING
- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
EN
N
NVCR
Novocure
17.96
+0.06+0.34%After Hours: 17.71 -0.25 -1.39%19:16 05/22 EDT
OPEN/PREV CLOSE17.98/17.90
TODAY RANGE17.78-18.17
VOL848.89K
MARKET CAP2.08B
52 WEEK RANGE9.82-20.06
AVG VOL (3M)1.69M
% TURNOVER0.73%
TURNOVER--
P/E (TTM)-11.7041
% RANGE2.18%
EPS(TTM)-1.5345
P/E(FORWARD)-11.0864
P/B6.29
BVPS2.855
DIVIDEND--
P/S3.083
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.87B
SHARES OUTSTANDING115.82M
NEXT EARNINGS07/20-08/04
FREE FLOAT104.27M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·3d ago
NovoCure Earnings Call Highlights Growth, One-Time Hit
Simply Wall St·05/14 09:46
NovoCure (NVCR) Is Up 9.7% After Raising 2026 Revenue Outlook And Posting Stronger Q1 Sales
Simply Wall St·05/09 04:44
A Look At NovoCure (NVCR) Valuation After Raised 2026 Revenue Guidance And Q1 Beat
NASDAQ·05/05 13:05
3 Overlooked Stocks Set to Soar in 2026
Simply Wall St·05/04 20:21
Why NovoCure (NVCR) Is Up 33.2% After FDA Clears Optune Pax And Guidance Ticks Higher
Dow Jones·05/04 19:08
Novocure Is Maintained at Equal-Weight by Wells Fargo
Benzinga·05/04 18:57
Wells Fargo Maintains Equal-Weight on NovoCure, Raises Price Target to $17
NASDAQ·05/04 13:15
International Markets and NovoCure (NVCR): A Deep Dive for Investors
TipRanks·05/04 10:36
Novocure price target raised to $17 from $13.50 at Wells Fargo
Simply Wall St·05/02 09:44
NovoCure’s Optune Pax Win And TRIDENT Data Shape Growth Outlook
Seeking Alpha·05/01 16:35
NovoCure: Pancreatic Launch Looks Promising, But I'm Not A Believer Yet
TipRanks·05/01 14:46
Wedbush Remains a Hold on NovoCure (NVCR)
Dow Jones·05/01 13:32
Novocure Price Target Raised to $20.00/Share From $16.00 by Evercore ISI Group
Dow Jones·05/01 13:32
Novocure Is Maintained at Outperform by Evercore ISI Group